Your browser doesn't support javascript.
loading
Chronic Neuregulin-1ß Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.
Gupte, Manisha; Lal, Hind; Ahmad, Firdos; Sawyer, Douglas B; Hill, Michael F.
Afiliação
  • Gupte M; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Lal H; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Ahmad F; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Sawyer DB; Department of Cardiac Services, Maine Medical Center, Portland, Maine.
  • Hill MF; Department of Professional and Medical Education, Meharry Medical College, Nashville, Tennessee. Electronic address: mhill@mmc.edu.
J Card Fail ; 23(12): 887-899, 2017 Dec.
Article em En | MEDLINE | ID: mdl-28870731

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxidantes / Apoptose / Neuregulina-1 / Diabetes Mellitus Tipo 1 / Insuficiência Cardíaca / Infarto do Miocárdio Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxidantes / Apoptose / Neuregulina-1 / Diabetes Mellitus Tipo 1 / Insuficiência Cardíaca / Infarto do Miocárdio Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article